Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies

Table 1

Health and demographic information for Parkinson’s disease patients with freezing of gait.

	Mean (±SD)
Age (years)	68.7 (1.97)
Disease duration (years)	6.4 (4.68)
NFOG	10 (3.36)
MoCA	27.50 (1.50)
LEDD	886 (385.5)
Oxford happiness	4.25 (0.61)
Verbal fluency
F	13.30 (4.29)
A	12.10 (5.36)
S	14.70 (6.14)
Animals	19.90 (4.81)
ANART	124.56 (5.62)
Sleepiness	8.80 (5.54)

Results are reported as means (±SD). NFOG = new freezing of gait questionnaire; MoCA = Montreal cognitive assessment; LEDD = levodopa equivalent daily dose; ANART = American national adult reading test. LEDD = L-dopa dose + (L-dopa dose × 1/3) if on entacapone + (bromocriptine (mg) × 10) + (cabergoline or pramipexole (mg) × 67) + (ropinirole (mg) × 20) + (pergolide (mg) × 100) + (apomorphine (mg) × 8).